Literature DB >> 10825166

Identification of a novel ligand-receptor pair constitutively activated by ras oncogenes.

R Zhang1, Z Tan, P Liang.   

Abstract

The Ras signaling pathway is thought to control the expression of a subset of yet to be defined genes that are crucial for cell growth and differentiation. Here we have identified by differential display a novel oncogenic Ras target, mob-5, encoding a 23-kDa cytokine-like secreted protein. Mob-5 expression could be induced by oncogenic Ha-ras and Ki-ras, but not by normal ras activation. Inhibitors of both Ha-Ras and mitogen-activated protein kinase kinase completely abolished the mob-5 expression in ras transformed cells, with concomitant loss of the transformation phenotype. Using an alkaline phosphatase-tagged Mob-5 as ligand, a putative Mob-5 receptor was identified on the cell surface of oncogenic ras transformed cells. Thus, the Mob-5/Mob-5 receptor may represent a novel putative autocrine loop coordinately activated by ras oncogenes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10825166     DOI: 10.1074/jbc.M001958200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Alternative splicing directs two IL-20R2 isoforms and is responsible for the incomplete gene knockout via the exon I ablation.

Authors:  H Zhou; X Liu; R Yu; T Long; R Zhao; H Liu; Y Xu; J G Liang; P Liang
Journal:  Genes Immun       Date:  2016-03-24       Impact factor: 2.676

2.  Interleukin-24 and its receptors.

Authors:  Mai Wang; Peng Liang
Journal:  Immunology       Date:  2005-02       Impact factor: 7.397

3.  mda-7 (IL-24) Mediates selective apoptosis in human melanoma cells by inducing the coordinated overexpression of the GADD family of genes by means of p38 MAPK.

Authors:  Devanand Sarkar; Zao-Zhong Su; Irina V Lebedeva; Moira Sauane; Rahul V Gopalkrishnan; Kristoffer Valerie; Paul Dent; Paul B Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-11       Impact factor: 11.205

Review 4.  The Interleukin-10 Family of Cytokines and Their Role in the CNS.

Authors:  Amanda R Burmeister; Ian Marriott
Journal:  Front Cell Neurosci       Date:  2018-11-27       Impact factor: 5.505

Review 5.  Insights into the Mechanisms of Action of MDA-7/IL-24: A Ubiquitous Cancer-Suppressing Protein.

Authors:  Jinkal Modi; Abhishek Roy; Anjan K Pradhan; Amit Kumar; Sarmistha Talukdar; Praveen Bhoopathi; Santanu Maji; Padmanabhan Mannangatti; Daniel Sanchez De La Rosa; Jiong Li; Chunqing Guo; Mark A Subler; Jolene J Windle; Webster K Cavenee; Devanand Sarkar; Xiang-Yang Wang; Swadesh K Das; Luni Emdad; Paul B Fisher
Journal:  Int J Mol Sci       Date:  2021-12-22       Impact factor: 6.208

6.  The p38 MAPK regulates IL-24 expression by stabilization of the 3' UTR of IL-24 mRNA.

Authors:  Kristian Otkjaer; Helmut Holtmann; Tue Wenzel Kragstrup; Søren Riis Paludan; Claus Johansen; Matthias Gaestel; Knud Kragballe; Lars Iversen
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240

Review 7.  mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokine.

Authors:  Pankaj Gupta; Zao-zhong Su; Irina V Lebedeva; Devanand Sarkar; Moira Sauane; Luni Emdad; Michael A Bachelor; Steven Grant; David T Curiel; Paul Dent; Paul B Fisher
Journal:  Pharmacol Ther       Date:  2006-02-07       Impact factor: 12.310

Review 8.  IL-24: a classic cytokine and/or a potential cure for cancer?

Authors:  S Kreis; D Philippidou; C Margue; I Behrmann
Journal:  J Cell Mol Med       Date:  2008-12       Impact factor: 5.310

9.  Molecular targets and signaling pathways regulated by interleukin (IL)-24 in mediating its antitumor activities.

Authors:  Janani Panneerselvam; Anupama Munshi; Rajagopal Ramesh
Journal:  J Mol Signal       Date:  2013-12-30

10.  Functional Detection of TNF Receptor Family Members by Affinity-Labeled Ligands.

Authors:  Yang Xu; Lingmo Chang; Anliang Huang; Xiaojun Liu; Xinyu Liu; Hong Zhou; Joshua G Liang; Peng Liang
Journal:  Sci Rep       Date:  2017-07-31       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.